FDA awards "Generally Recognized as Safe" status to Cardioviva (Micropharma) to help reduce bad cholesterol

The FDA have awarded heart health probiotic, Cardioviva (Lactobacillus reuteri NCIMB 30242), from Micropharma Ttd, with "Generally Recognized as Safe" (GRAS) status. This designation signifies that Cardioviva is considered safe by experts to use as an ingredient in food. Of the top 10 probiotic supplements in the US, Cardioviva is one of two to achieve FDA's GRAS approval.

The specific Cardioviva strain has beneficial properties for cholesterol management, which Micropharma has demonstrated through peer-reviewed and published clinical studies. It is working with food companies on formulations of the product which are intended for use in a variety of foods including beverages, breakfast cereals, cheeses, fats and oils, frozen dairy desserts, grain products and pastas.